The U.S. Department of Health and Human Services (HHS) awarded a $54,600 firm-fixed-price purchase order to Nova Biomedical Corp, a manufacturer of medical equipment and diagnostics based in Waltham, Massachusetts. The contract is for the provision of FDA-approved Nova Biomedical glucose testing systems to the NIH Clinical Center in Bethesda, Maryland. The award has an ultimate completion date of September 21, 2023 and is not designated as a set-aside contract. Nova Biomedical has an extensive history of supplying critical medical equipment and supplies, including blood gas analyzers, COVID-19 testing equipment, and glucose monitoring systems, to various federal agencies such as the Department of Veterans Affairs, National Institutes of Health, and Defense Health Agency. The company also serves as a subcontractor, providing maintenance and equipment for NIH projects. This specific award is not associated with a larger indefinite delivery vehicle (IDV), but Nova Biomedical does hold a Blanket Purchase Agreement (BPA) with the VA's Veterans Health Administration VISN 16 for the supply of reagents and medical supplies.